findmyKOL

Mark Kuperwaser, MD

Basic profile

Beth Israel Deaconess Medical Center

ORCIDNone on fileNPI
RegionBoston, MA · NortheastSpecialtyOphthalmologyFocusOphthalmology
Last active 2020findmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2020Online presenceNot yet checkedPaymentsNone reportedNIH funding1990–1990Why? →

Mark Kuperwaser is an Ophthalmology physician affiliated with Beth Israel Deaconess Medical Center. OpenAlex indexes 16 publications with 337 citations (h-index 9).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
16publications

Distinct works indexed by OpenAlex.

337citations

Total citations across indexed works.

9h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
1NIH grants · 1990–1990

Federally funded research awards.

View funding

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Sensory organs

    84.8%
    Prostaglandin Analog49.9%
    Latanoprost93%Lumigan5%Travoprost2%
    Part D477 patients
    Carbonic Anhydrase Inhibitor21.3%
    Dorzolamide-Timolol90%Dorzolamide Hcl10%
    Part D204 patients

    + 4 more classes in this area

  • Cardiovascular

    9.5%
    Beta blocker9.5%
    Timolol Maleate100%
    Part D106 patients
  • Anti-infectives

    3.1%
    Macrolide2.7%
    Erythromycin100%
    Part D45 patients
    Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor0.4%
    Valacyclovir100%
    Part D<11 patients
Where care is delivered (Part B)66.5% facility · 33.5% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

1 NIH research award on record, funded 19901990 per NIH RePORTER. The latest:

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

11 more publications behind the reveal.Reveal →

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”